THE LAB TEST, REINVENTED

WIPO WIPO 2015

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke THE LAB TEST, REINVENTED wurde als Wortmarke am 12.10.2015 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 02. April 2019

Markenform Wortmarke
Aktenzeichen 1290371
Länder Australien Schweiz China Europäische Gemeinschaft Irland Indien Japan Südkorea Mexiko Norwegen Philippinen Russland Singapur
Basismarke US Nr. 86667635, 18. Juni 2015
Anmeldedatum 12. Oktober 2015
Ablaufdatum 27. August 2018

Markeninhaber

1701 Page Mill Road
Palo Alto, CA 94304
US

Markenvertreter

801 California Street, Silicon Valley Center US

Waren und Dienstleistungen

09 Computer software for healthcare monitoring; computer software for communicating medical test results to patients; computer software for communicating medical test results to service providers in the medical and healthcare fields; computer software for scheduling a laboratory test appointment; computer software for appointment scheduling; computer software for medical diagnostics testing and monitoring and for communicating medical test results to patients and service providers in the medical and healthcare fields; computer software for use in biomonitoring of humans and of animals; computer software for medical monitoring and analysis of medical data; computer software for analysis of body fluids; computer software for communication and data transfer between health care professionals and patients; computer hardware; mobile electronic devices, namely, tablet computers, mobile phones, personal digital assistants, and other cellular or wireless communication devices; downloadable electronic publications, namely, downloadable newsletters, blogs, e-zines, magazines, books, manuals, pamphlets, diaries and journals in the fields of healthcare, medicine, personal health and fitness, biomonitoring, medical diagnostics, monitoring and testing
35 Administering pharmacy reimbursement programs and services; Administration of patient reimbursement programs; billing; compiling of information into computer databases; management and compilation of computerized databases; administrative services relating to medical referrals; administrative services relating to physician referrals; medical billing support services; providing an internet-based database of patient medical information designed to facilitate sharing and maintenance of patient medical information between and amongst the patient and healthcare professionals providing services to the patient; maintaining patient medical records and files
36 Insurance claims processing; pharmaceutical benefit management services; pharmacy benefit management services; medical laboratory benefit management services
42 Medical and scientific research services in the fields of blood analysis health care and health care monitoring; pharmaceutical research services; pharmaceutical research and development; blood analysis services for scientific research purposes; chemical laboratories; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; genetic testing of laboratory animals for research purposes; biological research; biomedical research; laboratory research in the field of chemistry, biochemistry, biology, health and medicine; laboratory services, namely, pigment and color analysis; laboratory services, namely, imaging core lab services; medical research laboratory services; providing laboratory research services in the field of gene expression, namely, cancer biology; rental of laboratory apparatus and instruments; scientific laboratory services; providing via a web site technology that enables patients, physicians and other healthcare providers to generate, manage and exchange medical information
44 Medical evaluation services; medical evaluation services, namely, assessment of patients undergoing medical treatment; medical monitoring services; medical monitoring services, namely, monitoring the efficacy of therapy and total patient or consumer health; medical diagnostic testing, monitoring and reporting services; collection and preservation of human and animal blood; consulting services in the field of health; consulting services in the field of diagnostic medical testing; consulting services in the fields of health and healthcare; drug use testing services; drug, alcohol and DNA screening for medical purposes; health assessment services; health care; medical counseling; medical information; medical screening; medical services; medical testing for diagnostic or treatment purposes; providing information in the field of pet health; pet hospital services; providing via a web site medical information; providing via a website health and healthcare information; internet-based health care information services; providing health information; providing healthcare information; rental of medical equipment; veterinary special services
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
08. März 2019 2019/13 Gaz US RAW: Total Ceasing Effect
03. August 2018 2018/38 Gaz SG Ablehnung
06. April 2018 2018/18 Gaz NO Ablehnung
27. März 2018 2018/17 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
16. März 2018 2018/15 Gaz PH RAW: Rule 18ter(2)(i) GP following a provisional refusal
28. Februar 2018 2018/10 Gaz MX RAW: Rule 18ter(2)(ii) GP following a provisional refusal
25. Januar 2018 2018/4 Gaz JP RAW: Rule 18ter(2)(i) GP following a provisional refusal
19. Januar 2018 2018/4 Gaz CH RAW: Rule 18ter(2)(i) GP following a provisional refusal
26. Dezember 2017 2018/2 Gaz RU Ablehnung
08. September 2017 2017/44 Gaz RAW: Limitation
27. Juni 2017 2017/27 Gaz CN Ablehnung
12. April 2017 2017/17 Gaz KR Ablehnung
22. März 2017 2017/12 Gaz MX Ablehnung
07. März 2017 2017/12 Gaz IN Ablehnung
30. Januar 2017 2017/6 Gaz RU Ablehnung
25. Januar 2017 2017/7 Gaz CH Ablehnung
18. Januar 2017 2017/23 Gaz EM RAW: Rule 18ter(2)(ii) GP following a provisional refusal
14. Oktober 2016 2016/46 Gaz NO Ablehnung
13. Oktober 2016 2016/43 Gaz JP Ablehnung
29. September 2016 2016/41 Gaz KR Ablehnung
29. September 2016 2017/15 Gaz IE Ablehnung
22. Juni 2016 2016/26 Gaz AU Ablehnung
05. Mai 2016 2016/21 Gaz SG Ablehnung
18. April 2016 2016/21 Gaz IE Ablehnung
10. März 2016 2016/12 Gaz PH Ablehnung
09. März 2016 2016/13 Gaz EM Ablehnung
12. Oktober 2015 2016/8 Gaz US Eintragung

ID: 141290371